首页> 美国卫生研究院文献>Case Reports in Dermatological Medicine >A Case of Onychomycosis Caused by Rhodotorula glutinis
【2h】

A Case of Onychomycosis Caused by Rhodotorula glutinis

机译:一例由鼠李红霉菌引起的甲癣

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Rhodotorula spp. have emerged as opportunistic pathogens, particularly in immunocompromised patients. The current study reports a case of onychomycosis caused by Rhodotorula glutinis in a 74-year-old immunocompetent female. The causative agent was identified as R. glutinis based on the pinkish-orange color; mucoid-appearing yeast colonies on Sabouraud Dextrose Agar at 25°C; morphological evaluation in the Corn Meal-Tween 80 agar; observed oval/round budding yeast at 25°C for 72 hours; no observed pseudohyphae; positive urease activity at 25°C for 4 days; and assimilation features detected by API ID 32C kit and automated Vitek Yeast Biochemical Card 2 system. Antifungal susceptibility test results were as follows: amphotericin B (MIC = 0.5 µg/mL), fluconazole (MIC = 128 µg/mL), itraconazole (MIC = 0.125 µg/mL), voriconazole (MIC = 1 µg/mL), posaconazole (MIC = 0.5 µg/mL), anidulafungin (MIC = 0.5 µg/mL), and caspofungin (MIC = 16 µg/mL). Antifungal therapy was initiated with oral itraconazole at a dose of 400 mg/day; seven-day pulse therapy was planned at intervals of three weeks. Clinical recovery was observed in the clinical evaluation of the patient before the start of the third cure. Although R. glutinis has rarely been reported as the causative agent of onychomycosis, it should be considered.
机译:红景天属。已成为机会病原体,特别是在免疫功能低下的患者中。目前的研究报道了一例由74岁免疫能力强的Rhodotorula glutinis引起的甲癣。根据粉红色-橙色,将病原体鉴定为R. glutinis。在25°C时Sabouraud葡萄糖琼脂上出现黏液样的酵母菌落;玉米粉-吐温80琼脂的形态学评估;在25°C下观察到椭圆形/圆形萌芽酵母72小时;没有观察到假菌丝;在25°C下持续4天的尿素酶阳性活动; API ID 32C套件和Vitek Yeast生化卡2自动系统检测到的同化和同化特征。抗真菌药敏试验结果如下:两性霉素B(MIC =0.5μg/ mL),氟康唑(MIC =128μg/ mL),伊曲康唑(MIC =0.125μg/ mL),伏立康唑(MIC =1μg/ mL),泊沙康唑(MIC =0.5μg/ mL),阿尼芬净(MIC =0.5μg/ mL)和卡泊芬净(MIC =16μg/ mL)。口服伊曲康唑开始抗真菌治疗,剂量为400μmg/天;计划每三周间隔七天脉冲治疗。在第三次治疗开始之前,在对患者的临床评估中观察到临床恢复。尽管极少有报道认为R.glutinis是甲癣的病原体,但应考虑使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号